Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01988272
What this trial is testing

Imaging Based Dosimetry for Individualized Internal Emitter Therapy

Who this might be right for
Non-Hodgkin's Lymphoma
University of Michigan 33
Early research (Phase 1)Study completedNCT06151795
What this trial is testing

Evaluate XTR006 in Chinese Volunteers

Who this might be right for
Alzheimer Disease
Sinotau Pharmaceutical Group 10
Not applicableStudy completedNCT03262077
What this trial is testing

Dose Parameters for Photodynamic Therapy on Periodontal Disease

Who this might be right for
Chronic Periodontitis
University of Nove de Julho 30
Early research (Phase 1)Study completedNCT07253753
What this trial is testing

Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation

Who this might be right for
Healthy
Yellowbird Diagnostics Inc 12
Not applicableStudy completedNCT02088775
What this trial is testing

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct Cancer+4 more
Fox Chase Cancer Center 44
Not applicableEnded earlyNCT03516695
What this trial is testing

RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry

Who this might be right for
Liver Cancer
Boston Scientific Corporation 95
Very early researchStudy completedNCT00572598
What this trial is testing

Pilot Study of 18F Fluoropaclitaxel (FPAC)

Who this might be right for
Breast Cancer
Virginia Commonwealth University 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07835906
What this trial is testing

68Ga-NYM215 in NENs

Who this might be right for
Neuroendocrine Neoplasms
Peking Union Medical College Hospital 40
Very early researchEnded earlyNCT04712721
What this trial is testing

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Who this might be right for
Glioblastoma MultiformeBrain NeoplasmsGastroesophageal Adenocarcinoma+1 more
Novartis Pharmaceuticals 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844
What this trial is testing

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
Five Eleven Pharma, Inc. 60
Not applicableNot Yet RecruitingNCT07580651
What this trial is testing

Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring

Who this might be right for
Prostate CancerGynecologic Cancers
CISSS de Chaudière-Appalaches 20
Very early researchNot Yet RecruitingNCT07708103
What this trial is testing

Clinical Evaluation of [68Ga]Ga-FFD PET Imaging in Healthy Volunteers and Patients With Solid Tumors

Who this might be right for
Solid Tumor Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Early research (Phase 1)UnknownNCT06553846
What this trial is testing

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Fudan University 50
Early research (Phase 1)Study completedNCT03556046
What this trial is testing

89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE

Who this might be right for
Clear Cell Renal Carcinoma
Radboud University Medical Center 10
Very early researchLooking for participantsNCT07655869
What this trial is testing

[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma

Who this might be right for
Recurrent High-Grade GliomasRecurrent Glioblastoma IDH Wildtype
Beijing Tiantan Hospital 24
Testing effectiveness (Phase 2)Ended earlyNCT02328027
What this trial is testing

99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

Who this might be right for
Rheumatoid ArthritisAnkylosing Spondylitis
Advanced Accelerator Applications 16
Not applicableUnknownNCT03710018
What this trial is testing

Impact of Tumor Bed Localisation on Dosimetry Boost Irradiation in Patients Undergoing Breast Conserving Surgery

Who this might be right for
Breast Carcinoma
Tata Memorial Centre 21
Early research (Phase 1)Study completedNCT06345001
What this trial is testing

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers

Who this might be right for
Hepatocellular Carcinoma (HCC)Solid Tumors
Bayer 14
Early research (Phase 1)Looking for participantsNCT06211647
What this trial is testing

A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Ruimin Wang 20
Early research (Phase 1)Study completedNCT04105283
What this trial is testing

Tc99m-MAA Bronchial Artery Injection During Bronchial Embolization for Pulmonary Mass Induced Hemoptysis for Dosimetry Planning

Who this might be right for
Lung Cancer
Massachusetts General Hospital 8
Next Page